Peer-influenced content. Sources you trust. No registration required. This is HCN.

Annals of Internal MedicineApixaban vs. Rivaroxaban in Patients with Atrial Fibrillation and Valvular Heart Disease

When compared with rivaroxaban in a propensity score–matched cohort of 19,894 patients, apixaban was associated with an approximately 50% lower rate of ischemic stroke or systemic embolism and bleeding compared to rivaroxaban.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form